We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

185 hedge funds and large institutions have $860M invested in SANGAMO THERAPEUTICS INC in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 76 increasing their positions, 39 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 39

67% more call options, than puts

Call options by funds: $26.2M | Put options by funds: $15.7M

36% more capital invested

Capital invested by funds: $630M → $860M (+$230M)

4.74% more ownership

Funds ownership: 64.51% → 69.25% (+4.7%)

6% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 31

1% less funds holding

Funds holding: 187 → 185 (-2)

Holders
185
Holders Change
-2
Holders Change %
-1.07%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
76
Reduced
39
Closed
31
Calls
$26.2M
Puts
$15.7M
Net Calls
+$10.5M
Net Calls Change
+$2.07M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$71.5M
2
BG
Bellevue Group
Switzerland
+$38.8M
3
Citadel Advisors
Citadel Advisors
Florida
+$17.6M
4
BlackRock
BlackRock
New York
+$11.7M
5
N
Nuveen
North Carolina
+$8.41M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$9.23M
2
State Street
State Street
Massachusetts
-$5.37M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.96M
4
Bank of America
Bank of America
North Carolina
-$2.07M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
GEA
176
Glen Eagle Advisors
New Jersey
$2.75K +$1.38K +130 +104%
GWM
177
Geneos Wealth Management
Colorado
$2K +$2.13K +200 New
MWM
178
Merriman Wealth Management
Washington
$1.59K +$53.2K +5,000 +50%
AOWM
179
Alpha Omega Wealth Management
Virginia
$1K -$1.28K -120 -50%
CAC
180
Certified Advisory Corp
Florida
$1K – – –
NFG
181
Next Financial Group
Texas
$1K – – –
PCP
182
Proficio Capital Partners
Massachusetts
$1K – – –
VFA
183
Valeo Financial Advisors
Indiana
$1K – – –
LC
184
Lindbrook Capital
California
$1K +$1.59K +150 New
D.E. Shaw & Co
185
D.E. Shaw & Co
New York
– -$1.91M -179,575 Closed
ARTA
186
A.R.T. Advisors
New York
– -$1.09M -114,440 Closed
Handelsbanken Fonder
187
Handelsbanken Fonder
Sweden
– -$906K -95,000 Closed
QIM
188
Quantitative Investment Management
Virginia
– -$801K -84,000 Closed
GCP
189
GSA Capital Partners
United Kingdom
– -$620K -65,031 Closed
Capital Fund Management (CFM)
190
Capital Fund Management (CFM)
France
– -$521K -54,606 Closed
TF
191
TIAA FSB
Florida
– -$507K -53,194 Closed
SEC
192
Seven Eight Capital
New York
– -$448K -47,000 Closed
Jane Street
193
Jane Street
New York
– -$433K -45,450 Closed
LCM
194
Leisure Capital Management
California
– -$359K -37,656 Closed
OPPM
195
Opus Point Partners Management
New York
– -$320K -33,529 Closed
First Trust Advisors
196
First Trust Advisors
Illinois
– -$308K -32,254 Closed
HSBC Holdings
197
HSBC Holdings
United Kingdom
– -$291K -30,500 Closed
TMC
198
Trellus Management Company
Florida
– -$286K -30,000 Closed
VF
199
Virtu Financial
New York
– -$243K -25,430 Closed
HT
200
HAP Trading
New York
– -$248K -23,358 Closed
5 6 7
8
9

SGMO Hedge Fund Activity: Q2 2019 in Review

185 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2019, worth a combined $860M — up 36% from $630M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new SGMO positions and 31 closed out — a net gain of 2 holders — while 76 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $71.5M. The largest seller was Invesco, cutting an estimated $9.23M.

  • 185 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2019, down from 187 in Q1 2019.
  • Funds reported $860M of SANGAMO THERAPEUTICS INC stock for Q2 2019, up 36% quarter-over-quarter.
  • 33 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2019 and 31 closed out, a net change of +2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2019 was Wellington Management Group, an estimated $71.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2019 was Invesco, an estimated $9.23M sold.

Based on aggregated 13F filings for Q2 2019.